Wells Fargo lowered the firm’s price target on Ibotta (IBTA) to $86 from $95 and keeps an Overweight rating on the shares. The firm says that a promising earnings result was again offset by a guide down, the third in as many public company quarters. Wells sees the first half of 2025 growth recovery amid renewed budgets, expanding demand sources and improved sales products aimed at unlocking ROI-driven budgets.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IBTA:
- Ibotta downgraded to Neutral from Buy at UBS
- Ibotta, Inc. Reports Strong Q3 2024 Financial Results
- Closing Bell Movers: Tetra Tech down 8% after Q4 results, guidance
- Ibotta reports Q3 adjusted EPS 94c, consensus 35c
- Ibotta sees Q4 revenue $100M-$106M, consensus $110.29M
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
